Background: Allergy and allergic asthma are significant health burdens in developed
the role of the metalloproteinase ADAM10 on dendritic cells (DCs) in T H 2 immunity using models of allergic airway inflammation and anaphylaxis.
In prototypic antigen (ovalbumin (OVA) and aeroallergen (house dust mite (HDM)) models of allergic airway inflammation in mice, DCs have been extensively studied as initiators of T H 2 immunity. Specific cytokine milieus generated by DCs are important for initiating T H 2 responses, particularly expression of IL6 and lack of IL12p70. Recently, the transcription factor KLF4 has also been shown to be important for T H 2 immunity. 3 Further, certain costimulatory molecules, OX40L, CD86, PDL2, and cell surface proteins, CD301b (MGL2), jagged 1, and jagged 2, on DCs also influence the priming of T cells toward T H 2. 4 We examined how DC ADAM10, a member of the A disintegrin and metalloproteinase (ADAM) family, which mediate ectodomain shedding, influenced the generation of T H 2 immune responses. This has not previously been explored although ADAM10 has been studied in many physiological and disease processes. 5, 6 Ligands for and IFNc, 13, 14 Alternaria alternata, a common fungal aeroallergen, which stimulates both T H 2 and T H 17 immune responses 15, 16 and
Citrobacter rodentium, an attaching and effacing enteric pathogen that elicits innate lymphocyte type 3 and T H 17 responses 17 were used. Our data demonstrates that T H 2 responses were consistently reduced and other T helper types were less affected.
| EXPE RIMENTAL PROCEDURES

| Mice
All animal experiments were performed with the approval of the VCU Institutional Animal Care and Use Committee. Mice were maintained in VCU animal facility in accordance with guidelines for the humane treatment of laboratory animals set forth by the NIH and AAALAC. ADAM10 flox mice 12 were bred to B6.Cg-Tg(Itgax-cre) Harbor, ME). 4C13RTg reporter mice were a kind gift from Bill Paul's laboratory at NIH/NIAID. 18 The 4C13RTg mice were bred to OT-II mice to generate 4C13R-OT-II mice. All mice were on the C57Bl/6 background, and healthy male and female six-to 12-week-old mice were used for experiments.
| Antibodies
Antibodies used were as follows: anti-mouse CD45R/B220 (clone RA3-6B2), PE anti-mouse CD95 (clone SA367H8), and APC anti-GL7
(clone GL7), (FITC anti-mouse CD4 (clone GK1. 
| HDM and Alternaria alternata models
Mice were immunized with HDM extract (Stallergenes Greer, Lenoir, NC, USA) as previously described. 19 After last i.n. administration, mice were subjected to forced oscillations using the Flexivent apparatus (Scireq Inc., Montreal, Canada) with increasing doses of methacholine. Bronchoalveolar lavage fluid (BALF) was collected, and stained cell types determined by flow cytometry. 20 Lung lobes were snap-frozen in liquid N 2 for RNA isolation or fixed in 10% formalin for hematoxylin and eosin staining. Serum was collected for total IgG1 and IgE and HDM-specific IgG1 ELISAs
21
; 50 lg Alternaria alternata extract was as previously described 15, 16 ; 24 hours after the last administration, BALF was collected and analyzed by flow cytometry. Single cell suspension from medLNs was restimulated with plate-bound anti-CD3e and monensin (Biolegend, San Diego, CA) for 4 hours and then examined for IL13, IFNc, and IL17 intracellular expression. Serum IgG1, IgE, and IgG2b were measured by ELISA.
| Quantitative polymerase chain reaction (qPCR)
RNA was isolated using TRIzol Reagent according to manufacturer's instructions. RNA was reverse-transcribed into cDNA using SuperScript IV and oligo dTs. Taqman probes and gene expression master mix or primers and PowerUp SYBR green master mix (LifeTech) were used with a QuantStudio3 system (Table S1 ). All qPCR reagents were from ThermoFisher, Waltham, MA.
| Active systemic anaphylaxis
Mice were immunized with 100 lg ovalbumin (OVA), 10 lg pertussis toxin, and 10 mg alum in saline. 22 At day 21, serum total and OVA- Figure 1A ,B). Total affinity NP-specific IgG1 was only significantly different in the recall, while ADAM10 DCÀ/À had significantly less high-affinity NP-specific IgG1 at day 21 and more dramatically 5 days after boost ( Figure 1A ,B). Total serum levels ( Figure 1C) were not different. Antigen-specific IgE is not detectable even in WT mice; however, total IgE levels were lower in the ADAM10 , and WT mice. ADAM10 is the primary sheddase of CD23, and ADAM10-deficient B cells express higher levels of CD23 than WT B cells. 12 Splenic B220 + cells from ADAM10 DCÀ/À mice expressed a similar level of CD23 on the surface as WT, which was less than ADAM10 BÀ/À mice (Fig. S1A, S1B ).
We further demonstrate the difference between knocking out ADAM10 from DCs compared to B cells in the ASA model used in Figure 3 . ADAM10 BÀ/À mice exhibit anaphylaxis upon OVA challenge similar to WT and have to be euthanized due to severe temperature drop, whereas ADAM10 DCÀ/À mice are resistant to anaphylaxis (Fig. S1C) . These results strongly suggest that ADAM10 deficiency on B cells does not occur in ADAM10 DCÀ/À mice and is not involved in the phenotype of these mice. protocol and then challenged with OVA on day 25 after immunization. A, After challenge, core body temperature was measured. B, -E, Mice were bled on day 21 after immunization. OVA-specific and total IgG1 and IgE were measured in the serum by ELISA. F, Mice were subjected to passive systemic anaphylaxis. IgE anti-DNP was injected ip into mice and then 24 hours later, mice were challenged ip with DNP-BSA and core body temperature measured. Data are from three independent experiments with n=11 mice per group. Data are presented as meanAESEM. **P<.01, *P<.05, unpaired Student's t test groups had cleared the infection by day 28 (Fig. S2A ). To further demonstrate the specificity of the T H 2 defect in ADAM10
DCÀ/À mice, responses to a fungal aeroallergen, A. alternata, and infections with A. phagocytophilum and C. rodentium were tested. After intranasal sensitization and challenge with A. alternata, we found that ADAM10 DCÀ/À mice had reduced eosinophils in the BALF compared to WT, consistent with the HDM model ( Figure 4A ). Interestingly, they had equivalent levels of neutrophils ( Figure 4B) Figure 4C ). Reduced amount of IgG1
and IgE was found in the serum of ADAM10 DCÀ/À mice, but we did not see any reduction in IgG2b (Figure 4D-F) . Antibody, BALF, and intracellular cytokine data reinforce the selective defect in T H 2 immunity present in ADAM10 DCÀ/À mice. After infection with the extracellular bacterium Citrobacter rodentium, ADAM10 DCÀ/À mice lost more body weight over the course of infection (Fig. S2B ) and were more likely to succumb (Fig. S2C) than WT. However, no differences were seen in total and CR-specific IgG2b (Fig. S2D, S2E ), similar to the response to fungal allergen. While colony counts indicated a similar infection level in the colon (Fig. S2F) , ADAM10 DCÀ/À mice had more disseminated infection as measured by CFUs in the spleen (Fig. S2G) . These data suggest that ADAM10 DCÀ/À mice were IFNc is crucial for pathogen elimination 13, 14 . ADAM10 DCÀ/À cleared this infection with similar efficiency as WT (Fig. S2A) . Overall, the primary defect in the ADAM10 DCÀ/À animals relates to T H 2 function.
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To further examine the role of DC Notch expression in the T H 2 impairment seen, two DC-specific Notch knockouts were used. Figure 6G and 2F,H). The transcription factor KLF4 is able to bind to and activate the Il6 promoter in DCs. 34 We show that both Klf4 and Il6 expression is reduced in ADAM10-deficient BMDCs ( Figure 6F ,G).
However, only Il6 expression was restored with N1-ICD expression, indicating that it may be responsible for the phenotype observed in ADAM10 DCÀ/À mice. Further support of this finding is that IL6 has been demonstrated to be upregulated by noncanonical Notch signaling and is dependent on N1-ICD. 35 Ever since IgE was discovered in the 1960s and the recognition of its importance in type I hypersensitivity, specific reduction in IgE synthesis has been a long sought mechanism to control these diseases. This has proven to be a difficult task, as this needs to be accomplished without significantly reducing protective immunoglobulin. This work demonstrates a clear reduction in T H 2-mediated disease and IgE production in ADAM10 DCÀ/À mice. In an earlier paper, we also demonstrated that the OVA 36 or HDM 24 allergy model was reduced when ADAM10 was deleted from B cells. However, the Bcell knockout has an overall reduction in all antibody classes, 10 while the ADAM10 DCÀ/À mice had primarily a T H 2 defect through Notch1.
While the C. rodentium data indicate Notch2 defects as well, the results presented here combined with fact that relatively specific delivery of drugs to lungs indicates that inhibition of ADAM10 on DCs in the lungs would represent a method to control the antigenspecific IgE production that plays a role in type I airway hypersensitivity. Current studies are examining this possibility using mouse models. If successful, this would have the potential of being a general therapy for T H 2-mediated airway diseases.
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